BioTelemetry (BEAT) Misses Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts BEAT Hot Sheet
Join SI Premium – FREE
BioTelemetry (NASDAQ: BEAT) reported Q3 EPS of $0.16, $0.09 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $81 million versus the consensus estimate of $82.62 million.
For earnings history and earnings-related data on BioTelemetry (BEAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- L3Harris CEO steps down amid conduct review, shares drop
- Tesla to launch Cybercab in Austin this month - report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
